David Tuller

Trial By Error: Hey Bristol, Where Is My Cease and Desist Letter?

By David Tuller, DrPH Earlier today, I e-mailed the following letter to Sue Paterson, University of Bristol's Director of Legal Services, to clarify whether or not I had been sent a cease and desist letter (to cease and desist what, exactly?). Professor Esther Crawley made this claim at her public ...

Trial By Error: My Brief Encounter with Professor Crawley

By David Tuller, DrPH At noon last Friday, at the University of Exeter's Mood Disorders Centre, Professor Esther Crawley gave a talk called What is new in paediatric CFS/ME research. When I saw a notice about the event the day before, I felt it might be my one chance to ...

Trial By Error: What’s Going On, BMJ Best Practice?

By David Tuller, DrPH Something's weird over at BMJ Best Practice, a resource for clinical decision-making and an arm of the BMJ Publishing Group. Two days ago, Steven Lubet and I posted a blog praising the new guide written by Dr. James Baraniuk and apparently reviewed by Peter White, along ...

Trial By Error: The Surprising New BMJ Best Practice Guide

By Steven Lubet, JD, and David Tuller, DrPH Update: Nov 13th We wrote this post based on a version of the guide that appeared recently and had been updated on July 31, 2017. That version lists Peter White as among three peer-reviewers. As commenters pointed out soon after the post ...

Trial By Error: Current NICE Guidance Stands, For Now

By David Tuller, DrPH Last week I sent an e-mail with some questions to Sir Andrew Dillon, the chief executive of the National Institute for Health and Care Excellence (NICE). In particular, the questions involved the status of the ten-year-old guidance for CFS/ME, CG53, and of references to the illness ...
Scroll to Top